Skip to main content
Fig. 2 | Advances in Rheumatology

Fig. 2

From: Treatment of knee osteoarthritis with a new formulation of a fixed-dose combination of glucosamine sulfate and bovine chondroitin: a multicenter, randomized, single-blind, non-inferiority clinical trial

Fig. 2

WOMAC a “pain” subscale, b “stiffness” subscale, c “physical function” subscale and d total score; e VAS overall assessment of OA by the patient; f VAS overall assessment of OA by the physician. Adjusted estimates and two-sided CI (95%) of absolute ranges for each variable in PP population. P value indicates the differences between the treatment groups and between week 24 visit and baseline assessment. OA: osteoarthritis; RP: reference product; VAS: visual analogue scale; WOMAC: Western Ontario and McMaster Osteoarthritis questionnaire

Back to article page

Advances in Rheumatology

ISSN: 2523-3106